Development of a real-time algorithm for predicting sufentanil plasma levels during cardiopulmonary-bypass surgery...

Area of Science:

• Anesthesiology
• Pharmacokinetics
• Cardiopulmonary Bypass

Background:

• Traditional narcotic administration during cardiopulmonary bypass (CPB) relies on general dosing and experience.
• Optimizing drug plasma concentrations requires understanding pharmacokinetics to blunt hemodynamic responses to surgical stimuli.

Purpose of the Study:

• To develop a computer-guided model for sufentanil administration during CPB.
• To address the lack of pharmacokinetic models for CPB due to limited data on bypass effects.

Main Methods:

• Developed a pharmacokinetic model for sufentanil during CPB.
• Applied a continuous temperature correction to the elimination rate constant to account for hypothermia.
• Incorporated effects of temperature on enzyme-catalyzed drug elimination.

Main Results:

• Presented an algorithm for applying the developed pharmacokinetic model.
• The model aims to optimize sufentanil plasma concentrations, reducing under- or overshooting.
• The approach models hypothermia's impact on sufentanil clearance.

Conclusions:

• The developed model and algorithm facilitate computer-guided sufentanil administration during CPB.
• This approach enhances the safety and effectiveness of narcotic analgesia in CPB procedures.
• Accurate pharmacokinetic modeling, including temperature effects, is crucial for optimizing drug delivery.